Back to News
Market Impact: 0.2
Precision Neuroscience Closes Oversubscribed $250M Series D Led by Pershing Square Inc., the Ackman Oxman Institute, and a Leading Life Sciences Investment Fund
Source: GlobeNewswire
Private Markets & VentureHealthcare & Biotech
Precision said its latest funding round brings total capital raised to $430 million. The company has completed more than 100 patient procedures across 18 major medical institutions, indicating early clinical adoption; the article does not disclose the size or terms of the new round.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
mildly positive
Sentiment Score
0.30
More News
- Eli Lilly’s Foundayo obesity pill eases sleep apnea in late-stage trial, paving way for approval
- Bon Secours affiliate sweetens bid for Surgery Partners to up to $6 billion
- CorMedix stock gains as Heron deal adds four products
- Rezolute at Guggenheim: FDA progress lifts rare-disease hopes
- Hims & Hers earnings up next: Can GLP-1 boom drive profit?
- Harrow earnings on deck as investors eye profitability return